BIO/DYNAMICS SUBSIDIARY OF APPLIED BIOSCIENCE INTERNATIONAL TO BEGIN TESTING ON AIDS PRODUCT FOR FUTURE MEDICAL PRODUCTS, INC.
BIO/DYNAMICS SUBSIDIARY OF APPLIED BIOSCIENCE INTERNATIONAL TO BEGIN TESTING ON AIDS PRODUCT FOR FUTURE MEDICAL PRODUCTS, INC. EAST MILLSTONE, N.J., March 31 /PRNewswire/ -- Dr. Geoffrey Hogan president of the Bio/dynamics subsidiary of Applied Bioscience International Inc. (NASDAQ: APBI), announced today that the company had signed a contractual agreement with Future Medical Products, Inc. of Hauppauge, N.Y., to commence testing necessary to meet U.S. Food and Drug Administration requirements for commercializing products using Future Medical's patented procedure utilizing an organic compound for the neutralization of AIDS. Hogan stated that Bio/dynamics was pleased to be working with the researchers at Albert Einstein College of Medicine who developed the compound, and Future Medical Products to help further the fight against AIDS. Applied Bioscience International Inc. provides a broad range of inter-related services, which include biological safety testing, clinical research and development, agrochemical research and development and the assessment and management of environmental risk. The company provides such services under contract to clients in the pharmaceutical, general chemical, agrochemical, nutritional and other industries throughout the world. -0- 3/31/92 /CONTACT: Dr. Geoffrey Hogan, president of Bio/dynamics, 908-873-2550, or John McNamara of John McNamara Advertising, 212-509-7779, for Bio/dynamics/ (APBI) CO: Applied Bioscience International Inc. ST: New Jersey IN: MTC SU: PDT
CK-SM -- NY034 -- 3315 03/31/92 10:17 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 31, 1992|
|Previous Article:||PAULSON CAPITAL REPORTS RECORD REVENUES AND EARNINGS FOR FISCAL 1991|
|Next Article:||USLIFE CORPORATION ANNOUNCES REDEMPTION OF 7.75 PERCENT NOTES|